Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis.
Saved in:
| Title: | Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis. |
|---|---|
| Authors: | Hoberger M; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Zuber RL; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Burkhard-Meier A; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany., Di Gioia D; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Jurinovic V; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Institute for Medical Information Processing, Biometry, and Epidemiology, University Hospital, LMU Munich, Munich, Germany., Völkl M; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Güler SE; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Albertsmeier M; Department of General, Visceral and Transplantation Surgery, University Hospital, LMU Munich, Munich, Germany., Klein A; Orthopaedic Oncology, Department of Orthopaedics and Trauma Surgery, University Hospital, LMU Munich, Munich, Germany., Dürr HR; Orthopaedic Oncology, Department of Orthopaedics and Trauma Surgery, University Hospital, LMU Munich, Munich, Germany., Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Knösel T; Institute of Pathology, LMU Munich, Munich, Germany., Kunz WG; Bavarian Cancer Research Center (BZKF), Munich, Germany.; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., von Bergwelt-Baildon M; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Lindner LH; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany., Berclaz LM; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Luc.Berclaz@med.uni-muenchen.de.; Bavarian Cancer Research Center (BZKF), Munich, Germany. Luc.Berclaz@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. Luc.Berclaz@med.uni-muenchen.de. |
| Source: | Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2026 Jan 08; Vol. 152 (1), pp. 34. Date of Electronic Publication: 2026 Jan 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-1335 |
|---|---|
| DOI: | 10.1007/s00432-025-06410-8 |
